Q32 Bio, Inc. (QTTB)
5.85
+0.13
(+2.27%)
USD |
NASDAQ |
Apr 17, 16:00
5.86
+0.01
(+0.17%)
Pre-Market: 20:00
Q32 Bio EPS Diluted (Quarterly) : 4.584 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.778 |
| Armata Pharmaceuticals, Inc. | -3.42 |
| Artelo Biosciences, Inc. | -6.191 |
| Gossamer Bio, Inc. | -0.2085 |
| Century Therapeutics, Inc. | -0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 57.73M |
| Revenue (Quarterly) | 53.74M |
| Total Expenses (Quarterly) | -3.993M |
| Enterprise Value | 52.63M |
| Gross Profit Margin (Quarterly) | 99.83% |
| Earnings Yield | 39.29% |
| Operating Earnings Yield | 23.48% |
| Normalized Earnings Yield | 41.35 |